We have treated neuroinflammation as a cleanup problem. Neurons die, debris accumulates, microglia activate to clear the mess. But that might be backward. The emerging picture: chronic microglial activation actively drives neuronal death in ALS, Parkinson's, and Alzheimer's. The inflammatory response is not secondary—it is causal.

This hypothesis changes how we think about therapeutic targeting.